Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal Czech Filtered by asset FUL
Coverage 92,717 Raw stories ingested 8,002 rewritten in CS_CZ • 0 to rewrite (last 2 days).
Agents 7 waiting Pipeline agents
  • FMP Stock News Fetch every minute 43s ago
  • FMP Forex News Fetch every 5 min 43s ago
  • CoinGecko News Fetch every 5 min 43s ago
  • FIO Stock News Fetch every 10 min 9m ago
  • Patria Stock News Fetch every 10 min 9m ago
  • Editorial rewrite Rewrite every minute 43s ago
  • Asset sync Assets every 1 hour 49m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Language
Relevance
Clear
Details Date Content Source Relevance
2026-07-24 17:35 2d ago
2026-07-24 12:31 2d ago
H.B. Fuller klesl o 11 % po silných výsledcích
FUL H B Fuller Company
FMP Stock News 72
Original source text
A month has gone by since the last earnings report for H. B. Fuller (FUL - Free Report) . Shares have lost about 11% in that time frame, underperforming the S&P 500.

But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is H. B. Fuller due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its latest earnings report in order to get a better handle on the important drivers.

Key highlightsH.B. Fuller logged earnings (as reported) of $1.23 per share for the second quarter of fiscal 2026 (ended May 30, 2026), compared with 76 cents reported a year ago.

Barring one-time items, adjusted earnings for the quarter were $1.41 per share, up 19% year over year. It beat the Zacks Consensus Estimate of $1.37.

The company posted revenues of $950.3 million, up around 6% year over year. It surpassed the Zacks Consensus Estimate of $927 million. Organic growth was up 2.6%.

Adjusted EBITDA was $181 million, up 9% year over year, with a margin of 19.1% versus 18.4% a year ago.

Revenue growth was driven by pricing and currency, offsetting modest volume weakness. Margin expansion in the quarter reflected realized pricing and Quantum Leap restructuring, partially offset by higher variable compensation and currency impacts.

Segment PerformanceHHC: Revenues were $421.9 million with organic revenue up 3% year over year. Adjusted EBITDA was $75.6M (up 22% y/y) with a margin of 17.9%, up 230 basis points (bps). Strength was seen in medical, tape & label and end-of-line packaging, offset by weak flexible packaging.

EA: Revenues were $283.2 million with organic growth of roughly 5% excluding solar exit. Aerospace was up 30% while electronics and general industries rose by double digits. Automotive declined by mid-single digits. Adjusted EBITDA was $63.5 million (flat year over year), with a margin of 22.4% (down 50 bps) due to higher variable comparisons.

BAS: Revenues were $245.2 million with organic growth of 6%. Adjusted EBITDA of $41.4 million rose 10% year over year with a margin of 16.9% (up 20 bps), led by glass and infrastructure/mechanical strength.

Cash Flow, Balance Sheet, Capital AllocationOperating cash flow was $121 million (a second-quarter record), supporting roughly 750,000 share repurchases in the quarter. Net leverage improved to 3.1x. Management continues Quantum Leap restructuring and Project ONE ERP, which are contributing to efficiency and margin gains.

GuidanceThe company expects fiscal 2026 (ex-AMS) net revenues to be up mid-single digits with organic growth of low single digits. Currency impacts are expected to be positive 1-2%.

Adjusted EBITDA is projected to be $650-$675 million. Adjusted earnings per share for fiscal 2026 are now forecast to be $4.60-$4.90.

Cash flow from operations for fiscal 2026 is expected to be in the range of $300 million to $325 million, weighted to the second half.

Net revenues for the fiscal third quarter are projected to rise mid-single digits. The company sees adjusted EBITDA of $180-$190 million for the quarter.

Management expects pricing in high-single-digits in the second half and volumes down low- to mid-single-digits. BAS is positioned for a stronger second half, EA is expected to improve as the solar exit laps, while HHC is more exposed to consumer softness. The proposed AMS acquisition is excluded from fiscal 2026 guidance.

How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a upward trend in estimates review.

VGM ScoresAt this time, H. B. Fuller has a subpar Growth Score of D, however its Momentum Score is doing a lot better with a B. Charting a somewhat similar path, the stock has a score of A on the value side, putting it in the top quintile for this investment strategy.

Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.

OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise H. B. Fuller has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
2026-07-09 15:01 17d ago
2026-07-09 09:05 17d ago
H.B. Fuller zvýšila tržby i EBITDA díky cenám
FUL H B Fuller Company
FMP Stock News 78
Original source text
Key Takeaways H.B. Fuller is prioritizing higher-value markets after its portfolio realignment and Flooring business sale. FUL grew Q2 revenues 5.8% as pricing, restructuring savings and mix lifted margins despite softer volumes. H.B. Fuller projects fiscal 2026 revenue growth and higher EBITDA, with cash flow weighted to the second half. H.B. Fuller Company (FUL - Free Report) is no longer just a broad specialty chemicals story. The investment debate now centers on whether a cleaner portfolio, stronger pricing discipline and medical expansion can support steadier margins.

That setup looks constructive, but not one-sided. Softer consumer-linked demand, flexible packaging weakness and automotive pressure still limit the near-term volume story.

How FUL Is Reshaping Its BusinessFollowing its fiscal 2025 realignment and the sale of the North America Flooring business, H.B. Fuller reports through three segments: Hygiene, Health & Consumable Adhesives, Engineering Adhesives and Building Adhesive Solutions.

The mix spans packaging, converting, hygiene, healthcare, transportation, electronics, clean energy, aerospace, appliances, roofing, building envelope, HVAC insulation and infrastructure. The strategic direction is clear. FUL is shifting toward more resilient and higher-value niches instead of relying mainly on raw volume growth.

H.B. Fuller Pricing Still Drives ResultsPricing remains the clearest support for the current thesis. In the fiscal second quarter, net revenues rose 5.8% year over year to $950 million, while organic revenues increased 2.6%, helped by pricing that more than offset slightly lower volume.

Margin execution was also stronger. Adjusted gross margin expanded 200 basis points to 34.2%, driven mainly by pricing execution and restructuring savings. Adjusted EBITDA rose 9% to $181 million, while adjusted EBITDA margin improved 70 basis points to 19.1%.

Why FUL Still Faces Demand FrictionThe weaker side of the story is volume. The Hygiene, Health & Consumable Adhesives unit saw strength in medical, tape and label and end-of-line packaging, but flexible packaging remained weak.

Engineering Adhesives also had mixed trends. Aerospace, electronics and general industries were stronger, but automotive declined by mid-single digits. These pressures leave earnings more dependent on price, mix, sourcing and cost control than on a broad-based volume recovery.

Avery Dennison Corporation (AVY - Free Report) gives investors another way to look at materials tied to packaging and labeling demand. RPM International Inc. (RPM - Free Report) , with exposure to specialty coatings, sealants and building materials, is also relevant for investors tracking construction-linked materials trends.

What H.B. Fuller Expects NextFor fiscal 2026, H.B. Fuller still expects net revenues to increase in the mid-single digits and organic revenues to rise in the low single digits. Foreign currency translation is expected to add 1-2% to revenues.

Management now expects adjusted EBITDA of $650-$675 million and adjusted earnings of $4.60-$4.90 per share. Operating cash flow is projected at $300-$325 million, with cash generation weighted to the second half of the year.

FUL Signals for Momentum and ValueThe bottom line is that FUL has a credible margin story, but it still needs to prove that pricing, restructuring and mix can offset uneven end-market demand. The proposed Advanced Medical Solutions acquisition adds another potential higher-margin growth platform, but it also brings integration and leverage considerations.

Shares of FUL have lost 7.2% so far this year against the industry’s 15.7% rise.

Image Source: Zacks Investment Research

FUL currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The stock also has a VGM Score of A, with a Value Score of A, Momentum Score of A and Growth Score of C. That combination points to favorable value and momentum characteristics, while the Growth Score signals that growth questions have not fully disappeared.

Estimate revisions also remain supportive, with the current fiscal-year earnings estimate up 2.1% over the past four weeks. For investors, FUL looks best framed as a margin-and-mix execution story, not a simple volume recovery play.
2026-07-09 15:01 17d ago
2026-07-09 09:11 17d ago
H.B. Fuller míří do zdravotnictví a zvyšuje hrubou marži
FUL H B Fuller Company
FMP Stock News 78
Original source text
Key Takeaways FUL is expanding into medical through the proposed Advanced Medical Solutions acquisition to widen its market.FUL saw aerospace rise 30% and electronics post double-digit gains, offsetting weaker automotive demand.FUL used pricing to lift margins despite higher raw material costs, though volume trends remain soft. H.B. Fuller Company (FUL - Free Report) gives investors a focused way to track changing demand in specialty materials. The company is not relying on one end market or one margin lever.

Its current setup rests on three connected trends: deeper exposure to regulated medical markets, solid demand in aerospace and electronics and pricing actions aimed at offsetting inflation and supply disruptions.

H.B. Fuller Pushes Deeper Into MedicalMedical is becoming a more important part of H.B. Fuller’s portfolio. The proposed acquisition of Advanced Medical Solutions would expand the company into tissue bonding adhesives, surgical tapes, dressings and biosurgical products.

The deal is expected to increase H.B. Fuller’s total addressable market by $15 billion to $95 billion. It also supports the company’s goal of reaching an adjusted EBITDA margin of more than 20% by 2028.

This matters because medical demand tends to be more procedure-driven and regulated than many industrial or consumer applications. That can make the business mix less tied to short-cycle demand swings.

3M Company (MMM - Free Report) remains a relevant comparison for investors watching materials innovation across healthcare, electronics and industrial applications. Its breadth shows why higher-specification materials businesses often attract attention when customers need reliability and regulatory know-how.

FUL Benefits From Aerospace and ElectronicsFUL’s growth is not coming from medical alone. In Engineering Adhesives, organic growth was roughly 5% excluding the exit from the lower-margin solar business.

Aerospace was up 30%, while electronics and general industries posted double-digit gains. Those areas are helping offset softness in automotive, where demand remained weaker across regions.

These trends point to the value of higher-performance niches. FUL’s adhesives are tied to applications where reliability, qualification and technical service matter.

Avery Dennison Corporation (AVY - Free Report) is another materials name investors may watch when tracking specialty materials demand. Like FUL, it gives investors exposure to markets where product performance and customer-specific solutions can shape growth.

H.B. Fuller Navigates an Inflation EraPricing remains central to the FUL story. In the second quarter of fiscal 2026, pricing increased net revenues by 3% and more than offset slightly lower volume.

Adjusted gross margin rose 200 basis points to 34.2%, helped by pricing execution and restructuring savings. Adjusted EBITDA increased 9% to $181 million, with adjusted EBITDA margin improving to 19.1%.

The operating backdrop remains unsettled. Nearly 90% of raw materials were higher in the fiscal second quarter versus the first quarter, and more than 50 force majeure events remained in place.

Management expects high-single-digit pricing in the second half. That gives FUL a margin-defense lever, but it also shows that input-cost pressure has not fully eased.

Why FUL Still Needs Better Volume TrendsThe trend story is not a clean cyclical rebound. Volume weakness remains a constraint, especially in more consumer-linked parts of the portfolio.

Flexible packaging stayed soft, and automotive declined by mid-single digits. Management’s fiscal 2026 framework also includes low- to mid-single-digit volume declines in the second half.

That keeps the investment case tied to mix improvement, pricing and restructuring rather than broad volume recovery. FUL can still improve margins, but stronger demand would make the growth profile more balanced.

The solar exit also creates noise in Engineering Adhesives comparisons. As that headwind laps, healthier niches may become easier to see, but the company still needs better volume confirmation.

FUL Screens Well for This Trend SetupThe bottom line is that FUL is participating in attractive specialty materials trends, but the stock still needs a firmer volume backdrop to turn margin resilience into a more decisive growth story.

Shares of FUL have lost 7.2% so far this year against the industry’s 15.7% rise.

Image Source: Zacks Investment Research

FUL currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The stock also has a VGM Score of A, supported by a Value Score of A and Momentum Score of A. Those scores suggest the stock screens well for investors who focus on valuation and earnings-related momentum. The Growth Score of C keeps the signal more balanced, fitting a company with improving mix and pricing power but uneven end-market demand.

The setup is constructive, not risk-free. FUL’s medical expansion, aerospace and electronics exposure, and pricing execution give the stock useful support, while consumer softness, automotive pressure and input-cost volatility remain key areas to watch.
2026-06-30 10:38 26d ago
2026-06-30 05:25 26d ago
H.B. Fuller zvyšuje výhled zisku pro fiskální rok 2026 po silném 2. čtvrtletí
FUL H B Fuller Company
FMP Stock News 92
Original source text
Key Takeaways FUL beat Q2 estimates as pricing and restructuring lifted EBITDA, EPS and gross margin.FUL raised its fiscal 2026 profit outlook while projecting high-single-digit pricing in the back half.FUL says the AMS deal would expand its medical adhesives platform and lift margins within 24 months. H.B. Fuller Company (FUL - Free Report) used its second-quarter fiscal 2026 earnings call to make two points clear: pricing is gaining traction across the portfolio, and management sees medical adhesives as the next major leg of its portfolio shift.

The quarter itself came in ahead of the Zacks Consensus Estimate, but the bigger message was forward-looking. Executives spent as much time defending the durability of pricing and raw material assumptions as they did explaining the proposed Advanced Medical Solutions deal.

H.B. Fuller Leans on Price and MixChief executive officer Celeste Mastin said second-quarter execution benefited from global sourcing and rapid pricing actions during the petrochemical supply disruption. Adjusted EBITDA rose 9% year over year to $181 million. Adjusted EPS increased 19% to $1.41, beating the Zacks Consensus Estimate of $1.37. Revenues of $950.3 million topped the Zacks Consensus Estimate of $926.9 million, producing a surprise rate of 2.5%.

Chief financial officer John Corkrean said adjusted gross margin expanded 200 basis points to 34.2%, driven mainly by pricing execution and restructuring savings. Adjusted EBITDA margin improved 70 basis points to 19.1%, showing that pricing was doing more than simply offsetting costs.

Management also pointed to cash flow as a supporting signal. Operating cash flow reached a record second-quarter level of $121 million, while net debt to adjusted EBITDA improved to 3.1 times from 3.4 times a year earlier.

FUL Sees Uneven but Improving DemandMastin described a business that is still navigating mixed end-market conditions. Hygiene, Health and Consumable Adhesives posted 3% organic growth in the quarter, helped by pricing and better supply continuity, while Building Adhesive Solutions delivered 6.2% organic growth on strength in glass, infrastructure and mechanical applications.

Engineering Adhesives was more complicated. The press release showed a 1% organic decline, but during Q&A, Mastin said the segment would have posted about 5% organic growth excluding the lower-margin solar business exit, with aerospace up more than 30% and electronics and general industrials up double digits.

That left automotive and consumer-linked demand as the softer points. Management said volume was only slightly lower in the quarter, but both HHC and EA could face more pressure in the second half if consumer demand weakens further.

H.B. Fuller Lifts Full-Year Profit ViewCorkrean said year-to-date execution supported a higher midpoint for full-year guidance. H.B. Fuller now expects fiscal 2026 adjusted EBITDA of $650 million to $675 million and adjusted EPS of $4.6 to $4.9, while keeping its outlook for mid-single-digit revenue growth and low-single-digit organic growth.

Third-quarter guidance was also firm. Management expects revenues to increase at a mid-single-digit pace and adjusted EBITDA to come in between $180 million and $190 million. Cash flow from operations is now projected at $300 million to $325 million for the year.

The assumptions behind that outlook mattered as much as the figures. Mastin said pricing was running near 6% in May and projected high-single-digit pricing in the back half, while also warning that raw materials had not meaningfully eased and that intermittent shortages remained a risk.

FUL Makes Medical the Strategic CenterpieceThe call’s biggest strategic development was the proposed acquisition of Advanced Medical Solutions. Mastin framed AMS as a rare chance to accelerate H.B. Fuller’s move toward faster-growing, higher-margin and less cyclical medical end markets.

Management said the all-cash 285 pence-per-share offer implies an enterprise value of about GBP 715 million. AMS generated roughly $302 million of fiscal 2025 revenues and about $54 million of adjusted EBITDA after IFRS-to-GAAP conversion, and H.B. Fuller sees about $55 million of run-rate synergies from commercial and cost actions.

Executives argued the deal would expand H.B. Fuller’s medical adhesives platform more than fourfold and help push the combined medical business above 30% EBITDA margins by 2030. They also said the transaction should add about 100 basis points to consolidated EBITDA margin within 24 months of closing.

H.B. Fuller Faces Deal and Demand ScrutinyAnalyst questions focused on leverage, synergy credibility and the logic of buying non-adhesive product lines within AMS. In response, Corkrean said pro forma net leverage at close should be about 4 times, excluding run-rate synergies, with a path back to the 2.5 times to 3 times target range within two years.

A Baird analyst pressed on the unusually high-cost synergy target. Corkrean said about $14 million comes from in-flight Peters Surgical synergies, with the rest tied to public company cost removal, sourcing benefits and back-office rationalization.

On operating conditions, analysts also asked whether falling petrochemical prices could cause customer hesitation. Mastin pushed back, saying nearly 90% of H.B. Fuller’s raw materials were still higher than in the first quarter and that 52 force majeures remained in place.

FUL Leaves a More Assertive MessageThe overall tone coming out of the call was more assertive than defensive. Management repeatedly returned to three points: pricing is working, restructuring savings are landing and the company believes supply-chain disruption is reinforcing its competitive position.

At the same time, leadership did not dismiss the pressure points. Executives acknowledged weaker automotive demand, consumer risk in HHC and a temporarily higher leverage profile if the AMS deal closes.

Zacks Signals on FULFUL carries a Zacks Rank #3 (Hold), with a Value Score of B, Growth Score of C, Momentum Score of A and VGM Score of A. The Hold rating points to a more balanced near-term outlook than a clear outperform signal, while the stronger Value, Momentum and VGM readings indicate more favorable characteristics within those styles. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Style Scores are meant to complement, not override, the Zacks Rank. A Zacks Rank #3 can still be supported by better style grades, but the rank remains the first screen, and it can shift as earnings estimate revisions change after the quarter.
2026-06-25 08:31 1mo ago
2026-06-25 03:36 1mo ago
H.B. Fuller koupí Advanced Medical Solutions za 715 milionů GBP
FUL H B Fuller Company
FMP Stock News 86
Original source text
CompaniesJune 25 (Reuters) - U.S.-based adhesives maker H.B. Fuller (FUL.N), opens new tab will buy Advanced Medical Solutions Group (AMSU.L), opens new tab in a cash ​deal that values the British medical supplier at about £715 ‌million ($942.1 million) including debt, the companies said on Thursday.

The British company's shares rose 15.8% to 278 pence, the highest level since February 2023.

Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.

Here are ​some details:

H.B. Fuller to pay Winsford-based company shareholders 285 ​pence per share, a 35% premium to its May 20 ⁠closing price, the day before the offer period began.

Deal expected ​to close by end of 2026.

H.B. Fuller expects the deal to ​generate about $55 million in annual run-rate synergies by 2031.

Deal marks the latest overseas takeover of a London-listed company amid relatively low UK valuations.

Ends a long ​stretch of private equity interest in AMS, including TA Associates, which ​walked away in May without bidding, as well as reported interest from Bridgepoint.

"As ‌part ⁠of the combined larger medical adhesives platform, AMS and H.B. Fuller will benefit from enhanced commercial, manufacturing and distribution capabilities, which should accelerate the delivery of our strategy and broaden our offering ​to patients in ​the US, ⁠Europe and beyond," Grahame Cook, Chair of AMS, said.

AMS board has unanimously recommended the deal to ​its shareholders.

As of last close, AMS shares have risen ​16% ⁠since H.B. Fuller launched its unsolicited bid on May 20.

In May, activist Ancora urged the Minnesota-based H.B. Fuller to abandon its "irresponsible" pursuit ⁠of AMS ​and conduct a strategic review.

Ancora did not immediately ​offer a response for Reuters' request for comment on the deal. ($1 = 0.7590 pounds)

Reporting by Nithyashree ​R B in Bengaluru; Editing by Subhranshu Sahu and Harikrishnan Nair

Our Standards: The Thomson Reuters Trust Principles., opens new tab
2026-06-24 20:15 1mo ago
2026-06-24 16:05 1mo ago
H.B. Fuller zvýšil zisk a výnosy, zvedl výhled
FUL H B Fuller Company
FMP Stock News 92
Original source text
Reported EPS (diluted) of $1.23; Adjusted EPS (diluted) of $1.41, up 19% year-on-year

Net income of $68 million; Adjusted EBITDA of $181 million, up 9% year-on-year

Record second quarter operating cash flow; Repurchased 750 thousand shares in the quarter

Increases midpoint of full-year adjusted EBITDA and adjusted EPS guidance

ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (NYSE: FUL) today reported financial results for its second quarter that ended May 30, 2026.

Second Quarter 2026 Noteworthy Items:

Net revenue was $950 million, up 5.8% year-on-year; organic revenue was up 2.6% year-on-year; Gross margin was 33.6%; adjusted gross margin of 34.2% increased 200 basis points year-on-year driven mainly by pricing execution and restructuring savings; Net income was $68 million; adjusted EBITDA was $181 million, up 9% versus last year; adjusted EBITDA margin was 19.1%, up 70 basis points year-on-year; Reported EPS (diluted) was $1.23; adjusted EPS (diluted) was $1.41, up 19% year-on-year, driven by higher adjusted net income; Record second quarter operating cash flow of $121 million dollars, up approximately 10% year-on-year. Summary of Second Quarter 2026 Results:

The Company’s net revenue for the second quarter of fiscal 2026 was $950 million, up 5.8% versus the second quarter of fiscal 2025. Pricing increased net revenue by 3.0%, which more than offset slightly lower volume, resulting in a 2.6% organic revenue increase year-on-year. Foreign currency translation and the impact of acquisitions increased net revenue by 3.1% and 0.1%, respectively.

Gross profit in the second quarter of fiscal 2026 was $320 million. Adjusted gross profit was $325 million. Adjusted gross profit margin of 34.2% increased 200 basis points year-on-year. The impact of pricing execution and restructuring savings drove the majority of the year-on-year increase in adjusted gross profit margin.

Selling, general and administrative (SG&A) expense was $202 million in the second quarter of fiscal 2026 and adjusted SG&A was $196 million, up 11% year-on-year. Adjusting for the impact of foreign exchange and variable compensation related to higher projected income for the year, adjusted SG&A was up approximately 3% year-on-year.

Net income attributable to H.B. Fuller for the second quarter of fiscal 2026 was $68 million. Adjusted net income attributable to H.B. Fuller for the second quarter of fiscal 2026 was $78 million. Reported EPS (diluted) was $1.23 and adjusted EPS (diluted) was $1.41, up 19% year-on-year.

Adjusted EBITDA in the second quarter of fiscal 2026 was $181 million, up 9% year-on-year, driven principally by the impact of pricing execution and restructuring savings.

“We executed very well in the second quarter, delivering strong year-on-year revenue, EBITDA, and EPS growth, with results above the midpoint of our EBITDA guidance range,” said Celeste Mastin, president and chief executive officer. “Our global sourcing capabilities and swift pricing actions have enabled us to maintain supply continuity and reliably serve our customers through market disruption. These efforts, combined with our Quantum Leap restructuring initiative, have strengthened our competitive position and we remain confident in our ability to deliver strong financial results.”

Mastin continued, “While the external environment remains dynamic, our focus is clear: we are executing on what we can control, leveraging our competitive strengths, and continuing to build a business that is more durable and better positioned to deliver superior long-term growth.”

Balance Sheet and Working Capital:

Net debt at the end of the second quarter of fiscal 2026 was $1,958 million, down $58 million year-on-year. Net debt-to-adjusted EBITDA was 3.1X, down from 3.4X at the end of the second quarter of fiscal 2025.

Net working capital in the second quarter of fiscal 2026 was 16.4% as a percentage of annualized net revenue and decreased 260 basis points sequentially versus the first quarter. Cash flow from operations improved to $121 million, a record second quarter, driven primarily by higher net income. As previously communicated, cash flow delivery for 2026 is expected to be weighted to the second half of the year.

Fiscal 2026 Outlook:

As a result of our year-to-date performance, we are updating our previously communicated financial guidance for fiscal 2026:

Net revenue for fiscal 2026 is still expected to be up mid-single digits; organic revenue is still expected to be up low-single digits and the impact from foreign exchange is still expected to be positive 1% to 2%; Adjusted EBITDA for fiscal 2026 is now expected to be in the range of $650 million to $675 million; Adjusted EPS (diluted) is now expected to be in the range of $4.60 to $4.90; Cash flow from operations for fiscal 2026 is now expected to be in the range of $300 million to $325 million; Net revenue for the third quarter of 2026 is expected to be up mid-single digits; adjusted EBITDA for the third quarter of 2026 is expected to be in the range of $180 million to $190 million. Conference Call:

The Company will hold a conference call on June 25, 2026, at 9:30 a.m. CT (10:30 a.m. ET) to discuss its results. Interested parties may listen to the conference call on a live webcast. The webcast, along with a supplemental presentation, may be accessed from the Company’s website at https://investors.hbfuller.com. Participants must register prior to accessing the webcast using this link and should do so at least 10 minutes prior to the start of the call to install and test any necessary software and audio connections. A telephone replay of the conference call will be available from 12:30 p.m. CT on June 25, 2026, to 10:59 p.m. CT on July 1, 2026. To access the telephone replay dial 1-800-770-2030 (toll free) or 1-609-800-9909 and enter the Conference ID: 6370505.

Regulation G:

The information presented in this earnings release regarding consolidated and segment organic revenue growth, operating income, adjusted gross profit, adjusted gross profit margin, adjusted selling, general and administrative expense, adjusted income before income taxes and income from equity investments, adjusted income taxes, adjusted effective tax rate, adjusted net income, adjusted diluted earnings per share, adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA), adjusted EBITDA margin, net debt, net debt-to-adjusted EBITDA, trailing twelve months adjusted EBITDA, net working capital, annualized net revenue and net working capital as a percentage of annualized net revenue does not conform to U.S. generally accepted accounting principles (U.S. GAAP) and should not be construed as an alternative to the reported results determined in accordance with U.S. GAAP. Management has included this non-GAAP information to assist in understanding the operating performance of the company and its operating segments as well as the comparability of results to the results of other companies. The non-GAAP information provided may not be consistent with the methodologies used by other companies. All non-GAAP information is reconciled with reported U.S. GAAP results in the “Regulation G Reconciliation” tables in this press release with the exception of our forward-looking non-GAAP measures contained above in our Fiscal 2026 Outlook, which the company cannot reconcile to forward-looking GAAP results without unreasonable effort.

About H.B. Fuller:

As the largest pureplay adhesives company in the world, H.B. Fuller’s (NYSE: FUL) innovative, functional coatings, adhesives and sealants enhance the quality, safety and performance of products people use every day. Founded in 1887, with 2025 revenue of $3.5 billion, our mission to Connect What Matters is brought to life by more than 7,100 global team members who collaborate with customers across more than 30 market segments in 150 countries to develop highly specified solutions that enable customers to bring world-changing innovations to their end markets. Learn more at www.hbfuller.com

Safe Harbor for Forward-Looking Statements:

Certain statements in this press release are forward-looking statements within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “opportunity,” “outlook,” “plan,” “project,” “seek,” “should,” “strategy,” “target,” “will,” “will be,” “will continue,” “will likely result,” “would” and similar expressions, and variations or negatives of these words or phrases. These statements are subject to various risks and uncertainties that could cause our actual results to differ materially from those in the forward-looking statements, including but not limited to the following: the availability and pricing of raw materials; the impact of potential cybersecurity attacks and security breaches; failures in our information technology systems; the impact on the supply chain, raw material costs and pricing of our products due to military conflict, including between Russia and Ukraine; the impact on our margins and product demand due to inflationary pressures; the substantial amount of debt we have incurred to finance our acquisition of Royal, our ability to repay or refinance our debt or to incur additional debt in the future, our need for a significant amount of cash to service and repay the debt and to pay dividends on our common stock, and the effect of debt covenants that limit the discretion of management in operating the business or in paying dividends; our ability to pay dividends and to pursue growth opportunities if we continue to pay dividends according to our current dividend policy; our ability to effectively manage and realize expected benefits from completed and future mergers, acquisitions, and divestitures; our ability to achieve expected synergies, cost savings and operating efficiencies from our restructuring initiatives and operational improvement projects within the expected time frames or at all; our ability to effectively implement Project ONE; uncertain political and economic conditions; fluctuations in product demand; competing products and pricing; our geographic and product mix; disruptions to our relationships with our major customers and suppliers; regulatory compliance across our global footprint; trade policies and economic sanctions impacting our markets; changes in tax laws and tariffs; devaluations and other foreign exchange rate fluctuations; the impact of litigation and investigations, including for product liability and environmental matters; impairment charges on our goodwill or long-lived assets; the consequences of catastrophic events on our operations and financial results; the effect of new accounting pronouncements and accounting charges and credits; and similar matters.

Additional information about these various risks and uncertainties can be found in the “Risk Factors” section of our Form 10-K filings, and any updates to the risk factors in our Form 10-Q and 8-K filings with the SEC, but there may be other risks and uncertainties that we are unable to identify at this time or that we do not currently expect to have a material impact on the business. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or revise any forward-looking statements, except as required by law.

Three Months Ended

Percent of

Three Months Ended

Percent of

May 30, 2026

Net Revenue

May 31, 2025

Net Revenue

Net revenue

$

950,271

100.0

%

$

898,095

100.0

%

Cost of sales

(630,617

)

(66.4

)%

(611,711

)

(68.1

)%

Gross profit

319,654

33.6

%

286,384

31.9

%

Selling, general and administrative expenses

(202,365

)

(21.3

)%

(186,340

)

(20.7

)%

Other income, net

5,627

0.6

%

7,141

0.8

%

Interest expense

(32,756

)

(3.4

)%

(34,865

)

(3.9

)%

Interest income

1,961

0.2

%

854

0.1

%

Income before income taxes and income from equity method investments

92,121

9.7

%

73,174

8.1

%

Income taxes

(25,584

)

(2.7

)%

(32,726

)

(3.6

)%

Income from equity method investments

1,268

0.1

%

1,397

0.2

%

Net income including non-controlling interest

67,805

7.1

%

41,845

4.7

%

Net income attributable to non-controlling interest

-

0.0

%

(17

)

(0.0

)%

Net income attributable to H.B. Fuller

$

67,805

7.1

%

$

41,828

4.7

%

Basic income per common share attributable to H.B. Fuller

$

1.25

$

0.77

Diluted income per common share attributable to H.B. Fuller

$

1.23

$

0.76

Weighted-average common shares outstanding:

Basic

54,430

54,443

Diluted

55,069

54,952

Six Months Ended

Percent of

Six Months Ended

Percent of

May 30, 2026

Net Revenue

May 31, 2025

Net Revenue

Net revenue

$

1,721,115

100.0

%

$

1,686,758

100.0

%

Cost of sales

(1,165,413

)

(67.7

)%

(1,173,299

)

(69.6

)%

Gross profit

555,702

32.3

%

513,459

30.4

%

Selling, general and administrative expenses

(386,816

)

(22.5

)%

(366,968

)

(21.8

)%

Other income, net

12,377

0.7

%

10,347

0.6

%

Interest expense

(65,627

)

(3.8

)%

(66,906

)

(4.0

)%

Interest income

4,034

0.2

%

1,954

0.1

%

Income before income taxes and income from equity method investments

119,670

7.0

%

91,886

5.4

%

Income taxes

(33,006

)

(1.9

)%

(38,671

)

(2.3

)%

Income from equity method investments

2,186

0.1

%

1,894

0.1

%

Net income including non-controlling interest

88,850

5.2

%

55,109

3.3

%

Net income attributable to non-controlling interest

-

0.0

%

(33

)

(0.0

)%

Net income attributable to H.B. Fuller

$

88,850

5.2

%

$

55,076

3.3

%

Basic income per common share attributable to H.B. Fuller

$

1.63

$

1.01

Diluted income per common share attributable to H.B. Fuller

$

1.61

$

0.99

Weighted-average common shares outstanding:

Basic

54,580

54,721

Diluted

55,291

55,490

Three Months Ended

Six Months Ended

May 30,

May 31,

May 30,

May 31,

2026

2025

2026

2025

Net income attributable to H.B. Fuller

$

67,805

$

41,828

$

88,850

$

55,076

Adjustments:

Acquisition project costs1

1,395

3,602

2,325

13,430

Organizational realignment2

4,413

6,635

14,435

15,409

Project One3

2,387

2,581

5,440

5,646

Other4

3,024

44

2,929

44

Discrete tax items5

356

13,961

454

14,952

Income tax effect on adjustments6

(1,848

)

(3,999

)

(5,386

)

(9,907

)

Adjusted net income attributable to H.B. Fuller7

77,532

64,652

109,047

94,650

Add:

Interest expense

32,584

34,484

64,957

66,514

Interest income

(1,961

)

(854

)

(4,030

)

(1,954

)

Adjusted Income taxes

27,075

22,765

37,937

33,626

Depreciation and Amortization expense8

45,815

44,613

91,838

87,180

Adjusted EBITDA7

$

181,045

$

165,660

$

299,749

$

280,016

Diluted Shares

55,069

54,952

55,291

55,490

Adjusted diluted income per common share attributable to H.B. Fuller7

$

1.41

$

1.18

$

1.97

$

1.71

Revenue

$

950,271

$

898,095

$

1,721,115

$

1,686,758

Adjusted EBITDA margin6

19.1

%

18.4

%

17.4

%

16.6

%

Three Months Ended

Six Months Ended

May 30,

May 31,

May 30,

May 31,

2026

2025

2026

2025

Net Revenue:

Hygiene, Health and Consumable Adhesives

$

421,861

$

397,475

$

768,388

$

765,700

Engineering Adhesives

283,239

276,418

525,688

513,177

Building Adhesive Solutions

245,171

224,202

427,039

407,881

Corporate unallocated

-

-

-

-

Total H.B. Fuller

$

950,271

$

898,095

$

1,721,115

$

1,686,758

Segment Operating Income:

Hygiene, Health and Consumable Adhesives

$

56,370

$

43,401

$

85,361

$

73,349

Engineering Adhesives

46,856

46,977

77,999

75,028

Building Adhesive Solutions

25,013

22,114

30,201

28,691

Corporate unallocated

(10,950

)

(12,448

)

(24,675

)

(30,577

)

Total H.B. Fuller

$

117,289

$

100,044

$

168,886

$

146,491

Adjusted EBITDA7

Hygiene, Health and Consumable Adhesives

$

75,564

$

61,963

$

123,601

$

108,854

Engineering Adhesives

63,544

63,341

111,703

107,529

Building Adhesive Solutions

41,414

37,535

63,024

59,337

Corporate unallocated

523

2,821

1,421

4,296

Total H.B. Fuller

$

181,045

$

165,660

$

299,749

$

280,016

Adjusted EBITDA Margin7

Hygiene, Health and Consumable Adhesives

17.9

%

15.6

%

16.1

%

14.2

%

Engineering Adhesives

22.4

%

22.9

%

21.2

%

21.0

%

Building Adhesive Solutions

16.9

%

16.7

%

14.8

%

14.5

%

Corporate unallocated

NMP

NMP

NMP

NMP

Total H.B. Fuller

19.1

%

18.4

%

17.4

%

16.6

%

NMP = non-meaningful percentage

Three Months Ended

Six Months Ended

May 30,

May 31,

May 30,

May 31,

2026

2025

2026

2025

Income before income taxes and income from equity method investments

$

92,121

$

73,174

$

119,670

$

91,886

Adjustments:

Acquisition project costs1

1,395

3,602

2,325

13,430

Organizational realignment2

4,413

6,635

14,435

15,409

Project One3

2,387

2,581

5,440

5,646

Other4

3,024

44

2,929

44

Adjusted income before income taxes and income from equity method investments9

$

103,340

$

86,036

$

144,799

$

126,415

Three Months Ended

Six Months Ended

May 30,

May 31,

May 30,

May 31,

2026

2025

2026

2025

Income Taxes

$

(25,584

)

$

(32,726

)

$

(33,006

)

$

(38,671

)

Adjustments:

Acquisition project costs1

(230

)

(1,120

)

(466

)

(3,800

)

Organizational realignment2

(727

)

(2,063

)

(3,276

)

(4,455

)

Project One3

(393

)

(803

)

(1,170

)

(1,638

)

Other4

(497

)

(14

)

(473

)

(14

)

Discrete tax items5

356

13,961

454

14,952

Adjusted income taxes10

$

(27,075

)

$

(22,765

)

$

(37,937

)

$

(33,626

)

Adjusted income before income taxes and income from equity method investments

$

103,340

$

86,036

$

144,799

$

126,415

Adjusted effective income tax rate10

26.2

%

26.5

%

26.2

%

26.6

%

Three Months Ended

Six Months Ended

May 30,

May 31,

May 30,

May 31,

2026

2025

2026

2025

Net revenue

$

950,271

$

898,095

$

1,721,115

$

1,686,758

Gross profit

$

319,654

$

286,384

$

555,702

$

513,459

Gross profit margin

33.6

%

31.9

%

32.3

%

30.4

%

Adjustments:

Acquisition project costs1

-

68

-

675

Organizational realignment2

2,583

2,467

7,521

7,923

Project One3

-

(94

)

-

1

Other4

2,500

-

2,501

-

Adjusted gross profit11

$

324,737

$

288,825

$

565,724

$

522,058

Adjusted gross profit margin11

34.2

%

32.2

%

32.9

%

31.0

%

Three Months Ended

Six Months Ended

May 30,

May 31,

May 30,

May 31,

2026

2025

2026

2025

Selling, general and administrative expenses

$

(202,365

)

$

(186,340

)

$

(386,816

)

$

(366,968

)

Adjustments:

Acquisition project costs1

1,223

3,654

1,660

11,360

Organizational realignment2

1,734

3,633

5,623

4,929

Project One3

2,387

2,676

5,440

5,646

Other4

523

44

1,925

44

Adjusted selling, general and administrative expenses12

$

(196,498

)

$

(176,333

)

$

(372,168

)

$

(344,989

)

Hygiene, Health

Building

Three Months Ended:

and Consumable

Engineering

Adhesive

Segment

Corporate

H.B. Fuller

May 30, 2026

Adhesives

Adhesives

Solutions

Total

Unallocated

Consolidated

Net income attributable to H.B. Fuller

$

58,862

$

47,958

$

27,887

$

134,707

$

(66,902

)

$

67,805

Adjustments:

Acquisition project costs1

-

-

-

-

1,395

1,395

Organizational realignment2

-

-

-

-

4,413

4,413

Project One3

-

-

-

-

2,387

2,387

Other4

-

-

-

-

3,024

3,024

Discrete tax items5

-

-

-

-

356

356

Income tax effect on adjustments6

-

-

-

-

(1,848

)

(1,848

)

Adjusted net income attributable to H.B. Fuller7

58,862

47,958

27,887

134,707

(57,175

)

77,532

Add:

Interest expense

-

-

-

-

32,584

32,584

Interest income

-

-

-

-

(1,961

)

(1,961

)

Adjusted Income taxes

-

-

-

-

27,075

27,075

Depreciation and amortization expense8

16,702

15,586

13,527

45,815

-

45,815

Adjusted EBITDA7

$

75,564

$

63,544

$

41,414

$

180,522

$

523

$

181,045

Revenue

$

421,861

$

283,239

$

245,171

$

950,271

-

$

950,271

Adjusted EBITDA Margin7

17.9

%

22.4

%

16.9

%

19.0

%

NMP

19.1

%

Hygiene, Health

Building

Six Months Ended

and Consumable

Engineering

Adhesive

Segment

Corporate

H.B. Fuller

May 30, 2026

Adhesives

Adhesives

Solutions

Total

Unallocated

Consolidated

Net income attributable to H.B. Fuller

$

90,346

$

80,195

$

35,949

$

206,490

$

(117,640

)

$

88,850

Adjustments:

Acquisition project costs1

-

-

-

-

2,325

2,325

Organizational realignment2

-

-

-

-

14,435

14,435

Project One3

-

-

-

-

5,440

5,440

Other4

-

-

-

-

2,929

2,929

Discrete tax items5

-

-

-

-

454

454

Income tax effect on adjustments6

-

-

-

-

(5,386

)

(5,386

)

Adjusted net income attributable to H.B. Fuller7

90,346

80,195

35,949

206,490

(97,443

)

109,047

Add:

Interest expense

-

-

-

-

64,957

64,957

Interest income

-

-

-

-

(4,030

)

(4,030

)

Adjusted Income taxes

-

-

-

-

37,937

37,937

Depreciation and amortization expense8

33,255

31,508

27,075

91,838

-

91,838

Adjusted EBITDA7

$

123,601

$

111,703

$

63,024

$

298,328

$

1,421

$

299,749

Revenue

768,388

525,688

427,039

1,721,115

-

1,721,115

Adjusted EBITDA Margin7

16.1

%

21.2

%

14.8

%

17.3

%

NMP

17.4

%

Hygiene, Health

Building

Three Months Ended:

and Consumable

Engineering

Adhesive

Segment

Corporate

H.B. Fuller

May 31, 2025

Adhesives

Adhesives

Solutions

Total

Unallocated

Consolidated

Net income attributable to H.B. Fuller

$

45,610

$

47,948

$

24,668

$

118,226

$

(76,398

)

$

41,828

Adjustments:

Acquisition project costs1

-

-

-

-

3,602

3,602

Organizational realignment2

-

-

-

-

6,635

6,635

Project One3

-

-

-

-

2,581

2,581

Other4

-

-

-

-

44

44

Discrete tax items5

-

-

-

-

13,961

13,961

Income tax effect on adjustments6

-

-

-

-

(3,999

)

(3,999

)

Adjusted net income attributable to H.B. Fuller7

45,610

47,948

24,668

118,226

(53,574

)

64,652

Add:

Interest expense

-

-

-

-

34,484

34,484

Interest income

-

-

-

-

(854

)

(854

)

Adjusted Income taxes

-

-

-

-

22,765

22,765

Depreciation and amortization expense8

16,353

15,393

12,867

44,613

-

44,613

Adjusted EBITDA7

$

61,963

$

63,341

$

37,535

$

162,839

$

2,821

$

165,660

Revenue

$

397,475

$

276,418

$

224,202

$

898,095

-

$

898,095

Adjusted EBITDA Margin7

15.6

%

22.9

%

16.7

%

18.1

%

NMP

18.4

%

Hygiene, Health

Building

Six Months Ended

and Consumable

Engineering

Adhesive

Segment

Corporate

H.B. Fuller

May 31, 2025

Adhesives

Adhesives

Solutions

Total

Unallocated

Consolidated

Net income attributable to H.B. Fuller

$

77,771

$

76,970

$

33,799

$

188,540

$

(133,464

)

$

55,076

Adjustments:

Acquisition project costs1

-

-

-

-

13,430

13,430

Organizational realignment2

-

-

-

-

15,409

15,409

Project One3

-

-

-

-

5,646

5,646

Other4

-

-

-

-

44

44

Discrete tax items5

-

-

-

-

14,952

14,952

Income tax effect on adjustments6

-

-

-

-

(9,907

)

(9,907

)

Adjusted net income attributable to H.B. Fuller7

77,771

76,970

33,799

188,540

(93,890

)

94,650

Add:

Interest expense

-

-

-

-

66,514

66,514

Interest income

-

-

-

-

(1,954

)

(1,954

)

Adjusted Income taxes

-

-

-

-

33,626

33,626

Depreciation and amortization expense8

31,083

30,559

25,538

87,180

-

87,180

Adjusted EBITDA7

$

108,854

$

107,529

$

59,337

$

275,720

$

4,296

$

280,016

Revenue

$

765,700

$

513,177

$

407,881

$

1,686,758

-

$

1,686,758

Adjusted EBITDA Margin7

14.2

%

21.0

%

14.5

%

16.3

%

NMP

16.6

%

Three Months Ended

Six Months Ended

May 30, 2026

May 30, 2026

Price

3.0

%

1.8

%

Volume

(0.4

)%

(3.5

)%

Organic Growth13

2.6

%

(1.7

)%

M&A

0.1

%

0.4

%

Constant currency

2.7

%

(1.3

)%

F/X

3.1

%

3.3

%

Total H.B. Fuller Net Revenue

5.8

%

2.0

%

Revenue growth versus 2025

Three Months Ended

May 30, 2026

Net Revenue

F/X

Constant Currency

M&A

Organic Growth13

Hygiene, Health and Consumable Adhesives

6.1

%

3.1

%

3.0

%

0.0

%

3.0

%

Engineering Adhesives

2.5

%

3.2

%

(0.7

)%

0.3

%

(1.0

)%

Building Adhesive Solutions

9.4

%

3.2

%

6.2

%

0.0

%

6.2

%

Corporate Unallocated

0.0

%

0.0

%

0.0

%

0.0

%

0.0

%

Total H.B. Fuller

5.8

%

3.1

%

2.7

%

0.1

%

2.6

%

Revenue growth versus 2025

Six Months Ended

May 30, 2026

Net Revenue

F/X

Constant Currency

M&A

Organic Growth13

Hygiene, Health and Consumable Adhesives

0.4

%

3.2

%

(2.8

)%

0.4

%

(3.2

)%

Engineering Adhesives

2.4

%

3.2

%

(0.8

)%

0.6

%

(1.4

)%

Building Adhesive Solutions

4.7

%

3.6

%

1.1

%

0.0

%

1.1

%

Corporate Unallocated

0.0

%

0.0

%

0.0

%

0.0

%

0.0

%

Total H.B. Fuller

2.0

%

3.3

%

(1.3

)%

0.4

%

(1.7

)%

Three Months Ended

Trailing 12 Months14 Ended

August 30, 2025

November 29, 2025

February 28, 2026

May 30, 2026

May 30, 2026

Net income attributable to H.B. Fuller

$

67,160

$

29,732

$

21,045

$

67,805

$

185,742

Adjustments:

Acquisition project costs1

518

1,465

931

1,395

4,309

Organizational realignment2

4,620

11,396

10,022

4,413

30,451

Project One3

2,499

2,091

3,053

2,387

10,030

Other15

1,711

37,400

(95

)

3,024

42,040

Discrete tax items16

(3,742

)

(3,743

)

98

356

(7,031

)

Income tax effect on adjustments6

(3,402

)

(7,745

)

(3,539

)

(1,848

)

(16,534

)

Adjusted net income attributable to H.B. Fuller7

69,364

70,596

31,515

77,532

249,007

Add:

Interest expense

33,369

32,547

32,373

32,584

130,873

Interest income

(1,110

)

(1,756

)

(2,069

)

(1,961

)

(6,896

)

Adjusted Income taxes

23,671

23,420

10,862

27,075

85,028

Depreciation and Amortization expense17

45,298

45,246

46,023

45,815

182,382

Adjusted EBITDA7

$

170,592

$

170,053

$

118,704

$

181,045

$

640,394

May 30, 2026

November 29, 2025

May 31, 2025

Total debt

$

2,072,151

$

2,016,937

$

2,112,428

Less: Cash and cash equivalents

114,102

107,213

96,785

Net debt18

$

1,958,049

$

1,909,724

$

2,015,643

Trailing twelve months14 / Year ended Adjusted EBITDA

$

640,394

$

620,660

$

593,604

Net Debt-to-Adjusted EBITDA18

3.1

3.1

3.4

May 30, 2026

February 28, 2026

May 31, 2025

Accounts receivable, net

$

622,745

$

532,180

$

584,026

Inventories

526,737

506,776

495,588

Accounts payable

(526,321

)

(453,035

)

(481,957

)

Net working capital19

$

623,161

$

585,921

$

597,657

Net revenue three months ended

$

950,271

$

770,844

$

898,095

Annualized net revenue19

3,801,084

3,083,376

3,592,379

Net working capital as a percentage of annualized revenue19

16.4

%

19.0

%

16.6

%

May 30,

November 29,

2026

2025

Assets

Current assets:

Cash and cash equivalents

$

114,102

$

107,213

Accounts receivable (net of allowances of $12,712 and $11,922, as of May 30, 2026 and November 29, 2025, respectively)

622,745

564,339

Inventories

526,737

471,963

Other current assets

135,836

119,750

Total current assets

1,399,420

1,263,265

Property, plant and equipment

2,034,140

1,956,209

Accumulated depreciation

(1,066,347

)

(1,020,948

)

Property, plant and equipment, net

967,793

935,261

Goodwill

1,693,481

1,680,059

Other intangibles, net

766,626

805,867

Other assets

501,473

498,254

Total assets

$

5,328,793

$

5,182,706

Liabilities, non-controlling interest and total equity

Current liabilities:

Accounts payable

$

526,321

$

470,132

Accrued compensation

95,728

114,302

Income taxes payable

19,909

25,018

Other accrued expenses

137,103

133,907

Total current liabilities

779,061

743,359

Long-term debt

2,072,151

2,016,937

Accrued pension liabilities

51,281

51,317

Other liabilities

343,836

367,899

Total liabilities

$

3,246,329

$

3,179,512

Commitments and contingencies

Equity

H.B. Fuller stockholders' equity:

Preferred stock (no shares outstanding) shares authorized – 10,045,900

-

-

Common stock, par value $1.00 per share, shares authorized – 160,000,000, shares issued and outstanding – 53,785,879 and 54,174,963 as of May 30, 2026 and November 29, 2025, respectively

$

53,786

$

54,175

Additional paid-in capital

275,507

298,017

Retained earnings

2,088,749

2,026,071

Accumulated other comprehensive loss

(335,578

)

(375,045

)

Total H.B. Fuller stockholders' equity

2,082,464

2,003,218

Non-controlling interest

-

(24

)

Total equity

2,082,464

2,003,194

Total liabilities, non-controlling interest and total equity

$

5,328,793

$

5,182,706

Six Months Ended

May 30, 2026

May 31, 2025

Cash flows from operating activities:

Net income including non-controlling interest

$

88,850

$

55,109

Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities:

Depreciation

48,772

44,837

Amortization

43,646

42,443

Deferred income taxes

(9,098

)

(14,068

)

Income from equity method investments, net of dividends received

(2,186

)

(1,894

)

Loss on the sale of business

-

1,515

Loss on impairment of intangible asset

-

478

Gain on sale or disposal of assets

(833

)

(101

)

Share-based compensation

12,580

12,003

Pension and other post-retirement plan benefit

(12,239

)

(11,039

)

Change in assets and liabilities, net of effects of acquisitions:

Accounts receivable, net

(53,893

)

(28,942

)

Inventories

(51,313

)

(40,182

)

Other assets

(9,291

)

2,364

Accounts payable

80,473

11,602

Accrued compensation

(19,643

)

(23,494

)

Other accrued expenses

13,522

1,097

Income taxes payable

(10,287

)

(10,587

)

Pension plan assets and liabilities

698

76

Other liabilities

(6,052

)

24,804

Foreign currency remeasurement

3,463

(8,252

)

Net cash provided by operating activities

117,169

57,769

Cash flows from investing activities:

Purchased property, plant and equipment

(104,380

)

(64,534

)

Proceeds from sale of property, plant and equipment

4,408

1,438

Payment of holdback on acquisitions

(11,627

)

-

Purchased businesses, net of cash acquired

-

(162,032

)

Purchase of cost method investment

-

(2,549

)

Proceeds from the sale of a business

-

75,727

Net cash used in investing activities

(111,599

)

(151,950

)

Cash flows from financing activities:

Proceeds from issuance of long-term debt

627,000

784,900

Repayment of long-term debt

(571,683

)

(687,751

)

Payment of debt issuance costs

-

(1,047

)

Net payment of notes payable

-

(588

)

Dividends paid

(25,970

)

(24,864

)

Proceeds from stock options exercised

10,266

2,475

Repurchases of common stock

(48,771

)

(60,664

)

Net cash (used in) provided by financing activities

(9,158

)

12,461

Effect of exchange rate changes on cash and cash equivalents

10,477

9,153

Net change in cash and cash equivalents

6,889

(72,567

)

Cash and cash equivalents at beginning of period

107,213

169,352

Cash and cash equivalents at end of period

$

114,102

$

96,785

More News From H.B. Fuller Company